Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 6, 1998, Pages 610-619

  Mori, Shigeki ^a   Aoyagi, Yutaka ^a   Yanagi, Masahiko ^a   Suzuki, Yasufumi ^a   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Concanavalin A non reactive species; Hepatocellular carcinoma; N acetylglucosaminyltransferase III; Transferrin

Indexed keywords

ALPHA FETOPROTEIN; CONCANAVALIN A; DECARBOXYPROTHROMBIN; N ACETYLGLUCOSAMINYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE III; TRANSFERRIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

EID: 0031756312     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00699.x     Document Type: Article

References (40)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull. World Health Organ. 1984; 62: 163-83.
2. Okuda K. The liver cancer study group of Japan. Primary liver cancer in Japan. Cancer 1980; 45: 2663-9.
3. Abelev GI. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res. 1968; 28: 1344-50.
4. O'Conor GI, Tatarinov YS, Abelev GI, Uriel J. A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer 1970; 25: 1091-8.
5. Liebman H, Furie BC, Tong MJ et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med. 1984; 310: 1427-31.
6. Okuda H, Obata H, Nakanishi T, Furukawa R, Hashimoto E. Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study. J. Hepatol. 1987; 4: 357-63.
7. Hattori N, Ohmizo R, Unoura M, Tanaka N, Kobayashi K. The PIVKA-II collaborative working group. J. Tumor Marker Oncol. 1988; 3: 207-16.
8. Schwerk WB, Schmitz-Moormann P. Ultrasonically guided fine-needle biopsies in neoplastic liver diseases: Cytohistologic diagnosis and echo pattern of lesions. Cancer 1981; 48: 1469-77.
9. Noguchi S, Yamamoto R,Tatsuta M et al. Cell features and patterns in fine-needle aspirate of hepatocellular carcinoma. Cancer 1986; 58: 321-8.
10. Shinagawa T, Ohto M, Kimura K et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 1984; 86: 495-502.
11. Ruoslahti E, Engvall E, Pekkala A, Seppälä M. Developmental changes in carbohydrate moiety of human alphafetoprotein. Int. J. Cancer 1978; 22: 515-20.
12. Breborowicz J, Mackiewicz A, Breborowicz D. Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand. J. Immunol. 1981; 14: 15-20.
13. Aoyagi Y, Suzuki Y, Isemura M et al. Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma. Gann 1984; 75: 809-15.
14. Buamah PK, Harris R, James OFW, Skillen AW. Lentillectin-reactive alpha-fetoprotein in the differential diagnosis of benign and malignant liver diseases. Clin. Chem. 1986; 32: 2083-4.
15. Aoyagi Y, Suzuki Y, Isemura M et al. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988; 61: 769-74.
16. Aoyagi Y, Suzuki Y, Igarashi K et al. Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: Presence of fucosylated and non-fucosylated triantennary glycans. Br. J. Cancer 1993; 67: 486-92.
17. Aoyagi Y, Isemura M, Suzuki Y et al. Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma. Lancet 1985; 2: 1353-4.
18. Aoyagi Y, Suzuki Y, Igarashi K et al. The usefulness of the simultaneous determination of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 1991; 67: 2390-4.
19. Taketa K, Sekiya C, Namiki M et al. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 1990; 99: 508-18.
20. Aoyagi Y. Carbohydrate-based measurement on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma. Glycoconj. J. 1995; 12: 194-9.
21. Sekine C, Aoyagi Y, Suzuki Y, Ichida F. The reactivity of alpha-1-antitrypsin with Lens culinaris agglutinin and its usefulness in the diagnosis of neoplastic diseases of the liver. Br. J. Cancer 1987; 56: 371-5.
22. Saitoh A, Aoyagi Y, Asakura H, Structural analysis on the sugar chains of alpha-1-antitrypsin: Presence of fucosylated biantennary glycan in hepatocellular carcinoma. Arch. Biochem. Biophys. 1993; 303: 281-7.
23. Suzuki Y, Aoyagi Y, Mori S, Suda T, Yanagi M Asakura H. Microheterogeneity of serum transferrin in the diagnosis of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1996; 11: 358-65.
24. Narasimhan S. Control of glycoprotein synthesis. J. Biol. Chem. 1982; 257: 10235-42.
25. Nishikawa A, Ihara Y, Hatakeyama M, Kanagawa K, Taniguchi N. Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: β-D-mannoside β-1,4N-acetylglucosaminyltransferase III from rat kidney. J. Biol. Chem. 1992; 267: 18199-204.
26. Miyoshi E, Nishikawa A, Ihara Y et al. N-acetylglucosaminyltransferase III and V messenger RNA level in LEC rats during hepatocarcinogenesis. Cancer Res. 1993; 53: 3899-902.
27. Nishikawa A, Fujii S, Sugiyama T, Taniguchi N. A method for the determination of N-acetylglucosaminyltransferase III activity in rat tissues involving HPLC. Anal. Biochem. 1988; 170: 349-54.
28. Ishibashi K, Nishikawa A, Hayashi N et al. N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients. Clin. Chim. Acta 1989; 185: 325-32.
29. Narasimhan S, Schachter H, Rajalakshmi S. Expression of N-acetylglucosaminyl-transferase III in hepatic nodules during rat liver carcinogenesis promoted by orotic acid. J. Biol. Chem. 1988; 263: 1273-81.
30. Suzuki Y, Aoyagi Y, Naitoh A et al. Microheterogeneity analysis of serum transferrin before and after therapies to hepatocellular carcinoma. Int. Hepatol. Commun. 1995; 4: 190-4.
31. MacGillivray RTA, Mendez E, Shewale JG, Sinha SK, Lineback-Zins J, Brew K. The primary structure of human transferrin, the structures of seven cyanogen bromide fragments and the assembly of the complete structure. J. Biol. Chem. 1983; 258: 3543-53.
32. Spik G, Debruyne V, Montreuil J, Halbeek H, Vliegenthart JFG. Primary structure of two sialylated triantennary glycans from human serotransferrin. FEBS Lett. 1985; 183: 65-9.
33. Yokota T. Structural analysis on the carbohydrate chains of human transferrin from sera of patients with hepatocellular carcinoma and liver cirrhosis, comparison with those of human alpha-fetoprotein. Acta Hepatol. Jpn 1994; 35: 587-95.
34. Baenziger JU, Fiete D. Structural determinations of concanavalin A specificity for oligosaccharides. J. Biol. Chem. 1979; 254: 2400-7.
35. Krusius T, Ruoslahti E. Carbohydrate structure of the concanavalin A molecular variants of alpha-fetoprotein. J. Biol. Chem. 1982; 257: 3453-7.
36. Bayard B, Kerckaert JP, Strecker G, Dorland L, Van Halbeek H, Vliegenthart JFG. Structure determination of the carbohydrate chains of rat α-fetoprotein. Eur. J. Biochem. 1983; 137: 319-23.
37. Yamashita K, Hitoi A, Tsuchida Y, Nishi S, Kobata A. Sugar chain of alpha-fetoprotein produced in human yolk sac tumor. Cancer Res. 1983; 43: 4691-5.
38. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: report 12. Acta Hepatol. Jpn 1997; 38: 317-30 (in Japanese).
39. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: report 12. Cancer 1987; 60: 1400-11.
40. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: report 8. Acta Hepatol. Jpn 1998; 29: 1619-26 (in Japanese).